Yubo International Biotech annual gross profit
2020
2021
2022
2023
2024
2025
Yubo International Biotech Gross Profit Growth & History (YBGJ)
Yubo International Biotech's gross profit was $8,165 for fiscal 2025.
View full Yubo International Biotech company overviewYubo International Biotech annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $8,165 | $5,517 | +208.35% |
| 2024 | 2024-12-31 | $2,648 | −$416,537 | −99.37% |
| 2023 | 2023-12-31 | $419,185 | $366,533 | +696.14% |
| 2022 | 2022-12-31 | $52,652 | −$767,995 | −93.58% |
| 2021 | 2021-12-31 | $820,647 | −$418,949 | −33.80% |
| 2020 · Dec 31 | 2020-12-31 | $1.2M | — | — |
Yubo International Biotech quarterly gross profit
Q1.20
Q1.21
Q2.21
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | $0 | — |
| Q1 2026 | 2026-03-31 | $0 | $0 | — |
| Q4 2025 | 2025-12-31 | $8,165 | $8,178 | — |
| Q3 2025 | 2025-09-30 | $0 | $0 | — |
| Q2 2025 | 2025-06-30 | $0 | $0 | — |
| Q1 2025 | 2025-03-31 | $0 | −$2,661 | — |
| Q4 2024 | 2024-12-31 | −$13 | −$16,541 | — |
| Q3 2024 | 2024-09-30 | $0 | −$344,082 | — |
| Q2 2024 | 2024-06-30 | $0 | −$885 | — |
| Q1 2024 | 2024-03-31 | $2,661 | −$55,029 | −95.39% |
| Q4 2023 | 2023-12-31 | $16,528 | −$12,407 | −42.88% |
| Q3 2023 | 2023-09-30 | $344,082 | $334,482 | +3484.19% |
| Q2 2023 | 2023-06-30 | $885 | −$4,966 | −84.87% |
| Q1 2023 | 2023-03-31 | $57,690 | $49,424 | +597.92% |
| Q4 2022 | 2022-12-31 | $28,935 | −$189,921 | −86.78% |
| Q3 2022 | 2022-09-30 | $9,600 | −$63,597 | −86.88% |
| Q2 2022 | 2022-06-30 | $5,851 | −$207,152 | −97.25% |
| Q1 2022 | 2022-03-31 | $8,266 | −$307,325 | −97.38% |
| Q4 2021 | 2021-12-31 | $218,856 | — | — |
| Q3 2021 · Sep 30 | 2021-09-30 | $73,197 | −$58,272 | −44.32% |
| Q2 2021 · Jun 30 | 2021-06-30 | $213,003 | −$40,420 | −15.95% |
| Q1 2021 · Mar 31 | 2021-03-31 | $315,591 | $315,591 | — |
| Q2 2021 · Sep 30 | 2020-09-30 | $131,469 | — | — |
| Q1 2021 · Jun 30 | 2020-06-30 | $253,423 | — | — |
| Q1 2020 · Mar 31 | 2020-03-31 | $0 | — | — |
Yubo International Biotech gross profit trends
Over the last five fiscal years, Yubo International Biotech's gross profit decreased from $1.2M to $8,165, a change of −$1.2M. The latest reported quarter, Q2 2026, shows $0.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Yubo International Biotech source filings ↗